USPTO serial 79270198
HISTOGUARD
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2020
- Examiner
- CIANCI, RYAN MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with HISTOGUARD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Matthew P. Hintz, Esq.
Matthew P. Hintz, Esq. Lowenstein Sandler LLPOne Lowenstein DriveLowenstein Sandler LLPRoseland, NJ 07068Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and technological services, research, consultancy, development and design, namely, clinical research in the field of cancer, oncology, neurological, inflammatory diseases, cancerous diseases, immunotherapy, histopathology, digital pathology, next generation immunohistochemistry, dna/mrna, fluorescence and silver in-situ hybridization, molecular pathology and all analytical methods covering morphological evaluation of specimens; medical laboratory services; clinical tests and clinical research, namely, conducting clinical trial services for others and providing advisory services related to the conduction of clinical trials; scientific laboratory services; analytical scientific laboratory services; scientific research for medical purposes in the area of cancerous diseases; providing information in the field of conducting clinical trials for others in the nature of scientific reports and reports related to scientific research and clinical tests; scientific and medical research; providing medical and scientific research information in the field of clinical trials; genetic testing for scientific research purposes; design and development of computer hardware and software | ACTIVE | — |
| 044 | Medical services; medical analysis services for the diagnosis of cancer, oncological, neurological and inflammatory diseases; medical testing for diagnosis and treatment purposes; advisory services relating to physical health care; medical analysis services for the diagnosis of cancer and other diseases; RNA and DNA screening for cancer diagnosis and prognosis; pathology services, namely, medical screening for cancer diagnosis and prognosis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Histogenex, naamloze vennootschap
- Other trademarks owned by Histogenex, naamloze vennootschap
- Other trademarks owned by Histogenex, naamloze vennootschap
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named HISTOGUARD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 15, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 23, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 31, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 30, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 15, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 15, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 30, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 30, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 27, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 10, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 10, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 10, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 28, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 28, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 28, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 28, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 28, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 21, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 23, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 22, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 2, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 1, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 28, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 28, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 24, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |